Sarkar FH - Search Results

1

Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.

Hwang C, Sethi S, Heilbrun LK, Gupta NS, Chitale DA, Sakr WA, Menon M, Peabody JO, Smith DW, Sarkar FH, Heath EI. Hwang C, et al. Among authors: sarkar fh. Am J Transl Res. 2016 Jan 15;8(1):166-76. eCollection 2016. Am J Transl Res. 2016. PMID: 27069550 Free PMC article.

2

High frequency of mutator phenotype in human prostatic adenocarcinoma.

Gao X, Wu N, Grignon D, Zacharek A, Liu H, Salkowski A, Li G, Sakr W, Sarkar F, Porter AT, et al. Gao X, et al. Oncogene. 1994 Oct;9(10):2999-3003. Oncogene. 1994. PMID: 8084604

3

Effects of lycopene supplementation in patients with localized prostate cancer.

Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP Jr. Kucuk O, et al. Among authors: sarkar fh. Exp Biol Med (Maywood). 2002 Nov;227(10):881-5. doi: 10.1177/153537020222701007. Exp Biol Med (Maywood). 2002. PMID: 12424329 Clinical Trial.

4

Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.

Bismar TA, Bianco FJ, Zhang H, Li X, Sarkar FH, Sakr WA, Grignon DJ, Che M. Bismar TA, et al. Among authors: sarkar fh. Pathology. 2003 Dec;35(6):513-7. doi: 10.1080/00313020310001619910. Pathology. 2003. PMID: 14660102

5

Differential expression of hZnT-4 in human prostate tissues.

Beck FW, Prasad AS, Butler CE, Sakr WA, Kucuk O, Sarkar FH. Beck FW, et al. Among authors: sarkar fh. Prostate. 2004 Mar 1;58(4):374-81. doi: 10.1002/pros.10344. Prostate. 2004. PMID: 14968438

6

Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein.

Nassar H, Pansare V, Zhang H, Che M, Sakr W, Ali-Fehmi R, Grignon D, Sarkar F, Cheng J, Adsay V. Nassar H, et al. Mod Pathol. 2004 Sep;17(9):1045-50. doi: 10.1038/modpathol.3800166. Mod Pathol. 2004. PMID: 15154007 Free article.

7

Cytochrome p450 and glutathione transferase expression in squamous cell cancer.

Ali S, El-Rayes BF, Heilbrun LK, Sarkar FH, Ensley JF, Kucuk O, Philip PA. Ali S, et al. Among authors: sarkar fh. Clin Cancer Res. 2004 Jul 1;10(13):4412-6. doi: 10.1158/1078-0432.CCR-04-0145. Clin Cancer Res. 2004. PMID: 15240530

8

Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.

Rahman KW, Sarkar FH. Rahman KW, et al. Among authors: sarkar fh. Cancer Res. 2005 Jan 1;65(1):364-71. Cancer Res. 2005. PMID: 15665315

9

A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P. Heath EI, et al. Clin Prostate Cancer. 2005 Sep;4(2):138-41. doi: 10.3816/cgc.2005.n.024. Clin Prostate Cancer. 2005. PMID: 16197617 No abstract available.

10

Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.

Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. Reddy GP, et al. Among authors: sarkar fh. J Cell Biochem. 2006 Aug 15;98(6):1408-23. doi: 10.1002/jcb.20927. J Cell Biochem. 2006. PMID: 16619263 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters